<code id='78EF08591C'></code><style id='78EF08591C'></style>
    • <acronym id='78EF08591C'></acronym>
      <center id='78EF08591C'><center id='78EF08591C'><tfoot id='78EF08591C'></tfoot></center><abbr id='78EF08591C'><dir id='78EF08591C'><tfoot id='78EF08591C'></tfoot><noframes id='78EF08591C'>

    • <optgroup id='78EF08591C'><strike id='78EF08591C'><sup id='78EF08591C'></sup></strike><code id='78EF08591C'></code></optgroup>
        1. <b id='78EF08591C'><label id='78EF08591C'><select id='78EF08591C'><dt id='78EF08591C'><span id='78EF08591C'></span></dt></select></label></b><u id='78EF08591C'></u>
          <i id='78EF08591C'><strike id='78EF08591C'><tt id='78EF08591C'><pre id='78EF08591C'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:9
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          The stability of $0 premiums in Medicare Advantage
          The stability of $0 premiums in Medicare Advantage

          PabloMartinezMonsivais/APYou’rereadingthewebeditionofHealthCareInc.,STAT’sweeklynewsletterfollowingt

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Be careful with at

          AdobeHypertensionisconsideredtobetheNo.1riskfactorfordeathglobally.Soit’snowonderconvenient,relative